What are the next steps for an 18-week pregnant woman with a single umbilical artery (SUA) and no other congenital anomalies found on routine anomaly scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Isolated Single Umbilical Artery at 18 Weeks

For an 18-week pregnant woman with isolated single umbilical artery and no other congenital anomalies, proceed with routine antenatal care plus enhanced third-trimester surveillance—no genetic counseling, no fetal echocardiography, and absolutely no termination is indicated. 1, 2

Immediate Management: No Additional Testing Required

Genetic Counseling: NOT Indicated

  • No additional evaluation for aneuploidy is recommended for isolated single umbilical artery, regardless of whether previous aneuploidy screening was low-risk or declined. 1, 2
  • Isolated SUA shows no increased risk of aneuploidy when no other structural abnormalities are present 2, 3
  • The Society for Maternal-Fetal Medicine explicitly states that diagnostic testing for aneuploidy is not recommended solely for an isolated soft marker following negative screening 1

Fetal Echocardiography: NOT Routinely Warranted

  • If the comprehensive cardiac assessment on the anatomy scan was adequate and normal, fetal echocardiography is not routinely warranted. 2
  • While cardiovascular anomalies are strongly associated with SUA (odds ratios 5.9-20.3), this applies when SUA occurs with other structural abnormalities 3
  • Since no congenital anomalies were found on the anomaly scan, additional cardiac imaging beyond the standard anatomic survey is unnecessary 2

Termination: Absolutely NOT Indicated

  • Termination is completely inappropriate for isolated SUA without associated anomalies 1, 2
  • Research shows that 84.6% of SUA cases are isolated and have excellent outcomes, with 98.5% live birth rates 4

Required Third-Trimester Surveillance Protocol

Growth Monitoring

  • Schedule a third-trimester ultrasound examination (typically 32-36 weeks) to evaluate fetal growth. 1, 2
  • This is critical because neonates with isolated SUA have increased rates of growth restriction, with 9.3% weighing less than the 5th percentile 2, 4
  • Even isolated SUA carries a 50% risk of growth restriction in some studies 5

Antenatal Fetal Surveillance

  • Consider weekly antenatal fetal surveillance beginning at 36 0/7 weeks of gestation. 1, 2
  • This recommendation is based on increased risks of stillbirth (nearly 5-fold increased risk, OR 4.80), polyhydramnios, oligohydramnios, placental abruption, and cord prolapse 2, 3
  • The perinatal mortality rate is approximately 10 times greater than the general population 6

Postnatal Planning

Pediatric Notification

  • Notify the pediatric team at delivery about the prenatal finding of isolated SUA. 2
  • Postnatal examination reveals structural anomalies in up to 7% of fetuses with prenatal diagnosis of isolated SUA that were not detected antenatally 2
  • This allows for appropriate newborn assessment and follow-up 2

Important Clinical Caveats

Why This Conservative Approach Works

The key distinction here is the word "isolated"—meaning no other structural abnormalities were detected on comprehensive anatomic survey 1, 2. When SUA occurs with other malformations, the frequency of aneuploidy ranges from 4-50%, but isolated SUA carries no increased chromosomal risk 3. The comprehensive anomaly scan already evaluated cardiac and renal anatomy (the most commonly affected systems), and these were normal 2, 3.

Common Pitfall to Avoid

Do not over-investigate isolated SUA with invasive testing or specialized imaging when the anatomy scan is normal 1, 2. The main risks with isolated SUA are growth restriction and stillbirth in the third trimester, not chromosomal abnormalities or structural defects 2, 4. Focus surveillance efforts where the actual risks lie: growth monitoring and late-pregnancy fetal well-being assessment 1, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Isolated Single Umbilical Artery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Single Umbilical Artery: Associated Findings and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prenatally Diagnosed Single Umbilical Artery (SUA) - Retrospective Analysis of 1169 Fetuses.

Ultraschall in der Medizin (Stuttgart, Germany : 1980), 2019

Related Questions

What is the next step for an 18-week pregnant female with a single umbilical artery (SUA) and no detected congenital anomalies?
What to do if a pregnant woman at 18 weeks gestation is found to have a single umbilical artery (SUA) with no congenital anomalies during a routine anomaly scan?
What is associated with a newborn having a single umbilical artery (two-vessel cord)?
What to do if a pregnant woman at 18 weeks has a single umbilical artery (SUA) with no congenital anomalies found on an anomaly scan?
What is the management and significance of a single umbilical artery (SUA) in pregnancy?
What is the appropriate management plan for a physically active adult with right thigh pain due to a multifocal partial-thickness tear of the vastus intermedius muscle and a resolving intramuscular hematoma, following blunt trauma, with Deep Vein Thrombosis (DVT) ruled out?
What is the best course of action for managing elevated blood pressure in a 45-year-old patient with a history of hypertension, currently taking Losartan 50mg (Angiotensin II receptor blocker) once daily, with recent elevated blood pressure readings and previous well-controlled blood pressure on the current medication regimen?
What study provides the most compelling evidence regarding the safety of normocept (novel cancer chemotherapy agent) for treating a rare form of cancer?
When is propofol (propofol) indicated for sedation in critically ill patients in the Intensive Care Unit (ICU)?
What is the safest antipsychotic option for a geriatric patient with epilepsy, dementia, schizophrenia, or bipolar disorder, and a history of QT (quantitative trait) interval prolongation?
What is a suitable muscle relaxer for an adult patient with shoulder muscle spasm, considering potential side effects and interactions with other medical conditions such as urinary retention, glaucoma, or impaired liver function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.